Weekly Digest – September 2026 Weekly Digest – September 2026 16 September 2026: Escugen and Sovran expand collaboration to co-develop a novel bispecific ADC Escugen and Sovran Bio have entered into an agreement to co-develop a first-in-class, pan-tumor bispecific ADC, […]